BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 570121)

  • 1. Prolactin secretion inhibition by a new 8alpha-amino-ergoline, CH 29-171.
    Flückiger E; Briner U; Doepfner W; Kovacs E; Marbach P; Wagner HR
    Experientia; 1978 Oct; 34(10):1330-2. PubMed ID: 570121
    [No Abstract]   [Full Text] [Related]  

  • 2. Two novel prolactin release-inhibiting 8 alpha-amino-ergolines.
    Flückiger E; Briner U; Bürki HR; Marbach P; Wagner HR; Doepfner W
    Experientia; 1979 Dec; 35(12):1677-8. PubMed ID: 520501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two new dopamine agonists that are long acting in vivo but short acting in vitro.
    Grossman A; Yeo T; Delitala G; Hathway NR; Besser GM
    Clin Endocrinol (Oxf); 1980 Dec; 13(6):595-9. PubMed ID: 7226572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ergocryptine on prolactin secretion druing concurrent pregnancy and lactation in the rat.
    Flint DJ; Ensor DM
    J Reprod Fertil; 1979 Jul; 56(2):691-6. PubMed ID: 582608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromocriptine and alpha-ergocryptine do not inhibit oxytocin secretion in the lactating rat.
    Russell JA; Harrison DJ; McNeilly AS
    J Endocrinol; 1981 Apr; 89(1):91-8. PubMed ID: 6894307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic profile of CQP 201-403, a novel 8 alpha-amino-ergoline.
    Flückiger E; Briner U; Clark B; Closse A; Enz A; Gull P; Hofmann A; Markstein R; Tolcsvai L; Wagner HR
    Experientia; 1988 May; 44(5):431-6. PubMed ID: 3371446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between inhibitory effect on prolactin secretion and antitumor activity of new ergoline compounds on DMBA-induced tumors in rats.
    Formelli F; Zaccheo T; Di Salle E; Ornati G; Di Marco A
    Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1545-51. PubMed ID: 6416848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of 2-bromo-alpha-ergocryptine and 2-chloro-alpha-methylergoline-8beta-acetonitrile (lergotrile mesylate) on the prolactin secretion of the ewe.
    Hooley RD; Fell LR; Findlay JK
    Acta Endocrinol (Copenh); 1977 Dec; 86(4):722-7. PubMed ID: 411304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of lisuride and bromocriptine on inhibition of lactation and on serum prolactin levels: comparative double-blind study.
    Venturini PL; Horowski R; Maganza C; Morano S; Pedretti E; Ragni N; Semino F; De Cecco L
    Eur J Obstet Gynecol Reprod Biol; 1981 May; 11(6):395-400. PubMed ID: 7018950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indirect evidences of prolactin involvement in precocious puberty induced by hypothalamic lesions in female rats.
    Alvarez EO; Hancke JL; Advis JP
    Acta Endocrinol (Copenh); 1977 May; 85(1):11-7. PubMed ID: 577071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin response to TRH during inhibition of puerperal lactation with ergolinic drugs.
    Crosignani PG; Lombroso GC; Trojsi L; Caccamo A; Reschini E; Peracchi M
    Horm Metab Res; 1977 Mar; 9(2):163-4. PubMed ID: 405303
    [No Abstract]   [Full Text] [Related]  

  • 12. Lactation-inhibiting and prolactin-lowering effect of lisuride and bromocriptine: a comparative study.
    Van Dam LJ; Rolland R
    Eur J Obstet Gynecol Reprod Biol; 1981 Nov; 12(5):323-30. PubMed ID: 7333409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of ergot alkaloids on pituitary prolactin and prolactin-dependent processes.
    Floss HG; Cassady JM; Robbers JE
    J Pharm Sci; 1973 May; 62(5):699-715. PubMed ID: 4574586
    [No Abstract]   [Full Text] [Related]  

  • 14. [Our experience in the inhibition of lactation (Controlled clinical study with bromocriptine, methergoline and pyridoxine)].
    Vecchione A; Baccolo M
    Riv Ital Ginecol; 1980; 59(2-3):311-9. PubMed ID: 7020052
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial: Bromocriptine--a changing scene.
    Br Med J; 1975 Dec; 4(5998):667-8. PubMed ID: 1239326
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of lactation in rabbits by 2-Br-alpha-Ergokryptine-mesilate (CB154).
    Flückiger E; Billeter E; Wagner HR
    Arzneimittelforschung; 1976; 26(1):51-3. PubMed ID: 947176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ergolines as potential prolactin and mammary tumor inhibitors.
    Cassady JM; Floss HG
    Lloydia; 1977; 40(1):90-106. PubMed ID: 327183
    [No Abstract]   [Full Text] [Related]  

  • 18. The treatment of puerperal lactation with bromocriptine.
    Cooke I; Foley M; Lenton E; Preston E; Millar D; Jenkins A; Obiekwe B; McNeilly A; Parsons J; Kennedy G
    Postgrad Med J; 1976; 52suppl 1():75-80. PubMed ID: 959129
    [No Abstract]   [Full Text] [Related]  

  • 19. Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation.
    Rains CP; Bryson HM; Fitton A
    Drugs; 1995 Feb; 49(2):255-79. PubMed ID: 7729332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of inhibitors of pituitary prolactin release on testicular cholesterol stores, seminal vesicles weight, fertility, and lactation in mice.
    Bartke A
    Biol Reprod; 1974 Oct; 11(3):319-25. PubMed ID: 4480365
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.